Skip to main content
. 2022 Apr 2;12(4):471. doi: 10.3390/brainsci12040471

Figure 1.

Figure 1

(A) Maximal change in the product of the perpendicular diameter in MRI T1 contrast before and after HSRT with anlotinib in each patient. CR, complete response. PR, partial response. RANO, Response Assessment in Neuro-Oncology. Y, yes. (B) Follow-up duration, time to the best response, and time to recurrence in each patient.